Advertisement
Advertisement
CGC
Canopy Growth Corporation Common Shares
0.96
USDSponsored
-0.02
-1.81%
Mar 24, 15:59 UTC -4
Closed
Pre-Market
0.96
0.00
-0.07%
CGC Earnings Reports
Positive Surprise Ratio
CGC beat 16 of 41 last estimates.
39%
Next Report
Date of Next Report
May 28, 2026
Estimate for Q4 26 (Revenue/ EPS)
$76.30M
/-$0.10
Implied change from Q3 26 (Revenue/ EPS)
+2.35%
/-44.44%
Implied change from Q4 25 (Revenue/ EPS)
-2.16%
/-93.20%
Canopy Growth Corporation Common Shares earnings per share and revenue
On Feb 06, 2026, CGC reported earnings of -0.18 USD per share (EPS) for Q3 26, missing the estimate of -0.04 USD, resulting in a -292.16% surprise. Revenue reached 74.54 million, compared to an expected 72.38 million, with a 2.99% difference. The market reacted with a +1.85% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 5 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 76.30 million USD, implying an decrease of -44.44% EPS, and increase of 2.35% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Canopy Growth Corporation Common Shares's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Canopy Growth Corporation Common Shares reported EPS of -$0.18, missing estimates by -292.16%, and revenue of $74.54M, 2.99% above expectations.
How did the market react to Canopy Growth Corporation Common Shares's Q3 2026 earnings?
The stock price moved up 1.85%, changed from $1.08 before the earnings release to $1.10 the day after.
When is Canopy Growth Corporation Common Shares expected to report next?
The next earning report is scheduled for May 28, 2026.
What are the forecasts for Canopy Growth Corporation Common Shares's next earnings report?
Based on 5
analysts, Canopy Growth Corporation Common Shares is expected to report EPS of -$0.10 and revenue of $76.30M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement